Skip to main content
Livermore
Livermore
ZHEN

Amneal Pharmaceuticals, Inc.

AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723128

In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Amneal Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of AMRX: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders2001238+39
Shares126.1M2.74M135.8M+12.4M (+10.1%)
Value$998.7M$21.7M$1.14B+$160.9M (+16.5%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (53)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to AMRX in Q1 2025
InstitutionSharesValue% of portfolio
Nuveen, LLC2,336,628$19.6M0.01%
Cubist Systematic Strategies, LLC684,116$5.73M0.08%
Numerai GP LLC596,131$5.00M0.94%
Point72 Asset Management, L.P.446,000$3.74M0.01%
Jane Street Group, LLC246,161$2.06M0.00%
LSV Asset Management169,900$1.42M0.00%
Two Sigma Investments, LP167,700$1.41M0.00%
Susquehanna Fundamental Investments, LLC154,045$1.29M0.02%
Tudor Investment Corp Et Al152,304$1.28M0.01%
Healthcare of Ontario Pension Plan Trust Fund131,600$1.10M0.00%
Jennison Associates LLC71,426$598.5K0.00%
Los Angeles Capital Management LLC58,897$493.6K0.00%
Jain Global LLC58,180$487.5K0.01%
Thrivent Financial for Lutherans57,608$483.0K0.00%
EntryPoint Capital, LLC50,530$423.4K0.19%
OP Asset Management Ltd49,531$415.1K0.01%
Zacks Investment Management48,334$405.0K0.00%
Occudo Quantitative Strategies LP47,014$389.3K0.05%
Universal- Beteiligungs- und Servicegesellschaft mbH44,590$373.7K0.00%
Centiva Capital, LP43,298$362.8K0.02%
Vishria Bird Financial Group, LLC41,792$350.2K0.12%
Caxton Associates LLP40,440$338.9K0.01%
Allianz Asset Management GmbH38,900$326.0K0.00%
Susquehanna Portfolio Strategies, LLC38,521$322.8K0.14%
Virtus ETF Advisers LLC35,921$301.0K0.20%
Voloridge Investment Management, LLC35,574$298.1K0.00%
Ieq Capital, LLC34,327$287.7K0.00%
Contravisory Investment Management, Inc.31,454$263.6K0.06%
Dynamic Technology Lab Private Ltd29,200$244.0K0.04%
Corton Capital Inc.23,423$196.3K0.65%
Readystate Asset Management LP22,102$185.2K0.01%
Point72 Asia (Singapore) Pte. Ltd.20,089$168.3K0.04%
SIH Partners, LLLP19,536$163.7K0.01%
Axq Capital, LP18,299$153.3K0.06%
D. E. Shaw & Co., Inc.15,836$132.7K0.00%
Aigen Investment Management, LP15,066$126.3K0.02%
Versor Investments LP14,300$119.8K0.02%
Schonfeld Strategic Advisors LLC12,900$108.1K0.00%
Point72 (DIFC) Ltd6,752$56.6K0.01%
Headlands Technologies LLC3,685$30.9K0.00%
Public Employees Retirement System of Ohio2,691$22.6K0.00%
Coldstream Capital Management Inc1,763$14.8K0.00%
National Bank of Canada780$6.53K0.00%
Hillsdale Investment Management Inc.750$6.29K0.00%
Caitong International Asset Management Co., Ltd547$4.58K0.00%
Optiver Holding B.V.332$2.78K0.00%
GPS Wealth Strategies Group, LLC115$9640.00%
Parkside Financial Bank & Trust65$5450.00%
Jones Financial Companies LLLP50$4140.00%
Stephens Consulting, LLC45$3780.00%
JFS Wealth Advisors, LLC44$3690.00%
HFM Investment Advisors, LLC2$170.00%
Bay Harbor Wealth Management, LLC1$80.00%

Sold out (14)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of AMRX in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
ExodusPoint Capital Management, LP108,267$857.0K
Bellevue Group AG100,414$795.3K
Signature Wealth Management Partners, LLC66,666$528.0K
Y-Intercept (Hong Kong) Ltd58,111$460.2K
Tranquilli Financial Advisor LLC51,414$407.2K
Inceptionr LLC41,921$332.0K
Virtus Investment Advisers, Inc.34,510$273.3K
Entropy Technologies, LP32,757$259.4K
Vestcor Inc31,393$249.0K
Fox Run Management, L.L.C.20,435$161.8K
Brevan Howard Capital Management LP13,571$107.5K
Sherbrooke Park Advisers LLC12,274$97.2K
Straightline Group LLC11,600$91.9K
Aster Capital Management (DIFC) Ltd1,316$10.4K

Not filed for Q1 2025 yet (1)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AMRX in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC2,735,743$21.7M